Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$15.33M$15.33Mderived+1.1% vs Q4 2020 Net Income-$8.94M-$8.94MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$2,230,000N/M Operating Incomederived-$8,359,000N/M Operating Cash Flowderived-$9,026,000N/M Margins · derivedGross margin-14.5%−17.1 pt vs Q4 2020
Operating margin-54.5%−1.3 pt vs Q4 2020
Net margin-58.3%−1.2 pt vs Q4 2020
ended Dec 31, 2021 · filed Apr 8, 2022 · 98 d after period end